کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2408968 1103198 2007 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine
چکیده انگلیسی

We evaluated the cost-effectiveness of rotavirus vaccination in Uzbekistan from the healthcare system and societal perspectives. Disease burden was estimated using national statistics on hospitalizations and deaths, and international estimates of under-five mortality. Without vaccination, the risk for rotavirus hospitalization by age 5 is 10 per 1000 children. Rotavirus hospitalizations cost US$ 406,000 annually, of which US$ 360,000 (89%) is for medical expenses and US$ 46,000 (11%) is for non-medical and indirect costs. Rotavirus mortality rate at 0.7 per 1000 derived from national data was three-fold lower than the same rate calculated from international estimates of under-five mortality. Rotavirus vaccination could reduce hospitalizations and deaths by 91% and avert US$ 370,000 in hospitalization costs alone. Vaccination would be cost-effective with vaccine prices in a range of US$ 2–25 per child. However, the cost-effectiveness is greatly influenced by mortality, vaccine price and vaccine efficacy.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 25, Issue 2, 4 January 2007, Pages 373–380
نویسندگان
, , , , , , ,